The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting

被引:87
作者
Qi, JG
Du, JB
Tang, XY
Li, JA
Wei, B
Tang, CS
机构
[1] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China
[2] Peking Univ, Hosp 1, Electron Microscopy Lab, Beijing 100871, Peoples R China
[3] Peking Univ, Hosp 1, Dept Thorac Surg, Beijing 100871, Peoples R China
[4] Peking Univ, Hosp 1, Inst Cardiovasc Res, Beijing 100871, Peoples R China
关键词
nitric oxide; carbon monoxide; urotensin-II; pulmonary hypertension; left to right shunt;
D O I
10.1007/s00380-003-0739-3
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The mechanism of pulmonary. vascular structural remodeling and pulmonary hypertension induced by high pulmonary blood flow is still unclear. Nitric oxide (NO) and carbon monoxide (CO) are two gaseous molecules recently discovered; both can induce the relaxation of blood vessels and inhibit the proliferation of vascular smooth muscle cells. More recently, urotensin-II (U-II) has been considered as the most potent mammalian vasoconstrictor identified so far, which can promote the proliferation of vascular smooth muscle cells. The aim of this study was to investigate the alteration of micro- and ultrapathologic structure, gaseous molecules, and U-II in rats with pulmonary hypertension induced by increased pulmonary blood flow. Aortocaval shunting was produced in rats. After 11-weeks of shunting, pulmonary artery mean pressure (PAMP) was measured. Pulmonary vascular micro- and ultrastructure was examined. Meanwhile, the concentration of plasma NO and CO was measured by spectrophotometry. The expression of endothelial nitric oxide synthase (eNOS), heme oxygenase-1 (HO-1), and U-II by pulmonary arteries was detected by immunohistochemistry. The results showed that PAMP was significantly elevated after 11 weeks of aortocaval shunting (2.99+/-0.35 kPa vs 2.09+/-0.38 kPa, P<0.01). Muscularization of small pulmonary vessels and relative medial thickness of pulmonary arteries were obviously increased in shunt rats compared with controls. Ultrastructural changes were found in intrapulmonary arteries of shunt rats. Meanwhile, plasma NO concentration was increased and eNOS expression by pulmonary artery endothelial cells was significantly augmented in rats of the shunting group, but there was no significant difference in plasma CO level and HO-1 expression by pulmonary artery smooth muscle cells between shunting and sham groups. Urotensin-II expression by pulmonary artery endothelial cells and smooth muscle cells was significantly strengthened in shunt rats compared with sham rats. The results suggest that pulmonary vascular structural remodeling is an important pathologic basis of pulmonary hypertension induced by a left-to-right shunt. Upregulation of U-II might play an important role in the development of high pulmonary blood flow-induced pulmonary hypertension. Nitric oxide, as a modifying factor, might be involved in the regulation of pulmonary vascular structural remodeling.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 26 条
[1]
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[2]
AN IMPROVED MATHEMATICAL APPROACH FOR THE ASSESSMENT OF THE MEDIAL THICKNESS OF PULMONARY-ARTERIES [J].
BARTH, PJ ;
KIMPEL, C ;
ROY, S ;
WAGNER, U .
PATHOLOGY RESEARCH AND PRACTICE, 1993, 189 (05) :567-576
[3]
Pulmonary arterial compliance in children with atrial and ventricular septal defect [J].
Basnet, NB ;
Awa, S ;
Hishi, T ;
Yanagisawa, M .
HEART AND VESSELS, 2000, 15 (02) :61-69
[4]
Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension [J].
Black, SM ;
Fineman, JR ;
Steinhorn, RH ;
Bristow, J ;
Soifer, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (05) :H1643-H1651
[5]
CHALMERS AH, 1991, CLIN CHEM, V37, P1442
[6]
eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow [J].
Everett, AD ;
Le Cras, TD ;
Xue, C ;
Johns, RA .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1998, 274 (06) :L1058-L1065
[7]
Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow [J].
Fullerton, DA ;
Mitchell, MB ;
Jones, DN ;
Maki, A ;
McIntyre, RC .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (01) :190-197
[8]
NITRIC OXIDE-GENERATING VASODILATORS AND 8-BROMO-CYCLIC GUANOSINE-MONOPHOSPHATE INHIBIT MITOGENESIS AND PROLIFERATION OF CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
GARG, UC ;
HASSID, A .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (05) :1774-1777